A surprising brain discovery could help explain why we overeat fatty foods
A protein inside appetite-controlling brain cells may play an important role in preventing overeating and obesity, particularly when high-fat foods are readily available. Unexpected differences between males and females could also help explain why obesity risk—and responses to weight-loss drugs—can vary.
Obesity remains a significant global health concern, linked to various metabolic disorders. Diet plays a crucial role, with high-fat foods often being hard to resist. Appetite, however, is primarily controlled by the brain, though the exact mechanisms of how dietary fat interacts with these neural systems are not fully understood.
Researchers at Osaka Metropolitan University's Graduate School of Human Life and Ecology, led by Professor Shigenobu Matsumura, sought to explore this connection, focusing on a specific protein in the brain. This protein, optic atrophy 1 (OPA1), is involved in mitochondrial function and energy metabolism within hypothalamic MC4R neurons.
The team compared wild-type mice with genetically modified mice lacking OPA1 in MC4R neurons, providing these animals with unlimited access to soybean oil, a rich source of dietary fat. The results indicated that soybean oil raised OPA1 levels in male mice, but not in females. OPA1-deficient mice consumed more food, gained more weight over time, and eventually became obese.
When given the choice between regular food and soybean oil, OPA1-deficient mice chose the high-fat option more frequently and gained additional weight. This effect was more pronounced in females. Additionally, the researchers tested setmelanotide, an anti-obesity medication that targets MC4R neurons. In males, setmelanotide effectively reduced appetite in both control mice and OPA1-deficient mice.
However, in females lacking OPA1, its appetite-suppressing effects were notably weaker. Professor Matsumura concluded that these findings offer important insights into the relationship between neuronal energy metabolism and obesity, suggesting that sex-specific responses to OPA1 could inform the development of more targeted obesity treatments and personalized medicine approaches. The research was published in the FASEB Journal.
Written by urgent.news from ScienceDaily Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.